Covid-19 Information about the Institute: In following the recommendations from Ottawa Public Health, the Institute of Biochemistry is operating online and staff are working remotely. We are doing all we can to keep our community safe and to contribute to slowing the progression of COVID-19 in Ottawa and across the country.
Commitment to Equity, Diversity, and Inclusion
Faculty and staff in the Department of Biology and Institute of Biochemistry are committed to promoting equity, diversity, and inclusion in our programs. We recognize and celebrate the diversity and lived experiences of our students. We aspire for our classrooms and research groups to be supportive and affirming spaces for all people regardless of their race, gender, gender identity, sexual orientation, culture, religion, and socioeconomic status. We are committed to listening and learning how to best support our diverse student population.
Most importantly, this statement represents the beginning of an important and ongoing discussion occurring within our units. We will update this statement in the coming weeks and months as we develop plans for concrete actions to implement change.
Explore the Institute
The aim of biochemistry is to understand and explain the operation of living systems through a study of their chemical, molecular, and cellular properties. In the post-genomic era, discoveries in biochemistry are transforming medicine, agriculture, and industry.
The biochemistry programs at Carleton are also an excellent option for students considering applying to medicine and other health sciences professional programs. A degree in biochemistry will give you the tools to succeed in the 21st century.
Wednesday, January 20, 2021
Towards a Cure: Carleton Research Team Working on Stem Cell Therapy to Reverse Type 1 Diabetes
Carleton’s Jenny Bruin is part of a team of researchers that has been awarded a 5-year, $3 million grant from the Canadian Institutes of Health...
Carleton’s Jenny Bruin is part of a team of researchers that has been awarded a 5-year, $3 million grant from the Canadian Institutes of Health Research (CIHR) and JDRF Canada to develop a novel therapy that transplants insulin-secreting cells derived from stem cells into patients with Type 1 diabetes. “We want to replace them with beta cells...
Wednesday, December 2, 2020
Carleton Scientists Use AI and Big Data to Identify a Potential COVID-19 Peptide Treatment
Using artificial intelligence and Canada’s most powerful supercomputer, Ashkan Golshani and Frank Dehne analyzed millions of possible protein...
Using artificial intelligence and Canada’s most powerful supercomputer, Ashkan Golshani and Frank Dehne analyzed millions of possible protein interactions. They have been developing algorithms that predict protein communications and potential drug treatments since 2003 and, using the IBM Blue Gene/Q supercomputer, they were able to predict that there...
Wednesday, December 2, 2020
Carleton Researchers Developing Anti-Viral Peptide Treatments To Help Disrupt Inflammatory Responses to COVID-19
Treatments for COVID-19 can help us manage the pandemic, even without a vaccine. Carleton bioinformatics researchers, Biology Prof. Kyle Biggar and...
Treatments for COVID-19 can help us manage the pandemic, even without a vaccine. Carleton bioinformatics researchers, Biology Prof. Kyle Biggar and Systems and Computer Engineering Prof. James Green, are using artificial intelligence to identify the protein interactions that could be responsible for COVID-19’s most severe symptoms, and working to develop...